TABLE 4.

Subgroup Analyses

	Proportion (%) of Days Alive With LVAD Spent Engaged in ≥1 Health Care Encounter	Proportion (%) of Total Time Alive With an LVAD Spent Receiving Care
Age, y
<65 (n = 262)	23.6 (16.3–33.1)	5.2 (2.1–12.5)
≥65 (n = 111)	22.1 (15.9–30.2)	5.9 (2.9–14.8)
P value	0.70	0.12
Race
White (n = 200)	22.2 (16.6–30.3)	5.2 (2.3–12.6)
Black (n = 96)	24.1 (14.3–32.5)	6.6 (2.1–14.8)
Other (n = 77)	24.9 (16.3–33.5)	5.1 (2.1–11.6)
P value	0.7	0.4
Implant strategy
Bridge to transplant (n = 182)	24.4 (17.3–33.1)	5.2 (2.1–12.3)
Destination Therapy (n = 191)	21.5 (14.9–31.8)	5.8 (2.3–13.9)
P value	0.05	0.45
Device type
HeartMate II (n = 127)	21.5 (14.2–31.6)	5.1 (2.1–10.2)
HeartWare HVAD (n = 196)	24.5 (17.4–33.9)	6.4 (2.5–13.5)
HeartMate III (n = 50)	21.8 (13.8–28.4)	5.3 (1.5–15.0)
P value	0.04	0.35

Values are median (IQR), unless otherwise indicated.

Abbreviation as in Table 2.